Latest news, press releases, and SEC filings for Amneal Pharmaceuticals Inc (AMRX) https://caymanjournal.com/stock/AMRX en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 21:33:45 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is a "DEFA14A" filing, which is a **Definitive Additional Material** for a proxy statement. In plain English, it's not the official voting document itself, but **supplementary material** Amneal is sending to shareholders ahead of a vote. 👉 **Why it exists:** Amneal https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-173760 https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-173760 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing # 📄 What This Document Is 📰 This document is an 8-K, or a Current Report, which means Amneal is filing an urgent update with the SEC to inform the public about a major, material event that happened on or around April 22, 2026. Since the filing centers entirely on a large deal, it provides the det https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-168237 https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-168237 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 📜 What This Document Is 🧩 This filing is a Definitive Proxy Statement (DEFA14A), a legal document submitted to the U.S. Securities and Exchange Commission (SEC) that contains information for the company's annual meeting of stockholders. Because the filing is specifically "Soliciting Material un https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170519 https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170519 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **DEFA14A** filing, which stands for "Definitive Additional Materials" related to a proxy statement. Think of it as an update or supplement to an earlier proxy announcement. In this case, Amneal is using it to formally file and explain materials it shared on soci https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170732 https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170732 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **DEFA14A filing**, which stands for "Definitive Additional Materials" related to a proxy statement. Think of it as an add-on or supplement to a main proxy document. In this case, Amneal is using it to share an internal factsheet about its proposed acquisition of https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170531 https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170531 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 📜 What This Document Is This is a **DEFA14A filing**, which stands for "Definitive Additional Material" related to a proxy statement. Think of it as an official update sent to shareholders and the public about a vote they need to take. 👉 **Why it's filed:** Amneal is using this form to share a https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170525 https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170525 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 📄 What This Document Is This is a **DEFA14A**, a type of SEC filing called "Definitive Additional Materials." Think of it as an official press release or internal memo sent to shareholders and the public that's required to be filed with the SEC because it relates to a proxy vote. 👉 **In this ca https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170540 https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-170540 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This SEC filing is an 8-K report from Amneal Pharmaceuticals (AMRX). It announces a major acquisition by attaching the legal agreements that define the deal. Think of it as a public disclosure that says, "We're buying a company, and here are the exact contracts that spell https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-168231 https://caymanjournal.com/stock/AMRX/sec-filing/0001193125-26-168231 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing